Swedish Cancer Institute Revenue and Competitors
Estimated Revenue & Valuation
- Swedish Cancer Institute's estimated annual revenue is currently $54.6M per year.
- Swedish Cancer Institute's estimated revenue per employee is $297,000
Employee Data
- Swedish Cancer Institute has 184 Employees.
- Swedish Cancer Institute grew their employee count by 0% last year.
Swedish Cancer Institute's People
Name | Title | Email/Phone |
---|
Swedish Cancer Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8M | 37 | 6% | N/A | N/A |
#2 | $8.6M | 40 | 8% | N/A | N/A |
#3 | $7.3M | 34 | 10% | N/A | N/A |
#4 | $10.8M | 50 | 16% | N/A | N/A |
#5 | $74.3M | 250 | 3% | N/A | N/A |
#6 | $70.4M | 237 | 6% | N/A | N/A |
#7 | $24.3M | 90 | -7% | N/A | N/A |
#8 | $44M | 148 | 12% | N/A | N/A |
#9 | $30.8M | 114 | 6% | N/A | N/A |
#10 | $7.8M | 36 | -8% | N/A | N/A |
What Is Swedish Cancer Institute?
As a leader in cancer diagnosis and treatment since 1932, the Swedish Cancer Institute team offers the best available technology and procedures for treating cancer patients.
keywords:N/AN/A
Total Funding
184
Number of Employees
$54.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Swedish Cancer Institute News
2022-04-20 - Genentech-led team uncovers how cancer cells resist T cell attack in ... Fierce Biotech
Genentech-led team uncovers how cancer cells resist T cell attack in ... Fierce Biotech
2022-04-06 - 30 Under 35 | Next question: Jolyn Hull | 30under35 ... Wenatchee World
30 Under 35 | Next question: Jolyn Hull | 30under35 ... Wenatchee World
2022-03-22 - Obituary | Nena C Roman Harvey Family Funeral Home
Obituary | Nena C Roman Harvey Family Funeral Home
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $29.5M | 185 | 7% | N/A |
#2 | $36.8M | 186 | 9% | N/A |
#3 | $28.1M | 187 | 3% | $53.2M |
#4 | $28.8M | 187 | -6% | N/A |
#5 | $36M | 187 | -1% | N/A |